Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ovarian Neoplasms

Free Subscription 12.10.2026 2 Am J Obstet Gynecol 1 Ann Oncol 1 Br J Cancer 1 Cancer Lett 1 Eur J Obstet Gynecol Reprod Biol 1 Gynecol Oncol 4 Int J Gynecol Pathol 1 Lancet Oncol 1 Mol Ther Oncol 1 Oncogene 1 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. GANESAN S, Fierheller CT, Evans DG, Manchanda R, et al
   NBN is associated with an increased risk of ovarian cancer (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2026 Oct 3:S0002-9378(26)00536.
   PubMed        
   
   
2. WANG J, Qiu S
   Methodological considerations of NBN-associated ovarian cancer risk (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2026 Oct 3:S0002-9378(26)00535.
   PubMed        
   
   

   
   Ann Oncol

3. RAY-COQUARD I, O'Malley DM, Oaknin A, Madariaga A, et al
   Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.
   Ann Oncol. 2026 Oct 8:S0923-7534(26)06781-5. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Br J Cancer

4. KARAKULAK T, Moch H, von Mering C, Kahraman A, et al
   Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemia.
   Br J Cancer. 2026 Oct 3. doi: 10.1038/s41416-026-03638.
   PubMed         Abstract available
   
   

   
   Cancer Lett

5. SANTHAMMA B, Chacon J, Deemer E, Stary D, et al
   Endometriosis from initiation to innovation: Immune microenvironments, clonal lesion biology, and the emerging therapeutic pipeline.
   Cancer Lett. 2026;660:218845.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

6. CAYUELA L, Llueca M, Climent MT, Serra A, et al
   Generational shifts and temporal trends in ovarian cancer burden in Spain, 1999-2023.
   Eur J Obstet Gynecol Reprod Biol. 2026;327:115467.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

7. TEWARI KS
   Platinum resistant ovarian cancer - No longer a graveyard for drug development.
   Gynecol Oncol. 2026;214:34-42.
   PubMed         Abstract available
   
   

   
   Int J Gynecol Pathol

8. XU J, Weisman PS
   SOX2 Can Support a Diagnosis of PiMHEC With Rare to Absent Ghost Cells and Can Distinguish PiMHEC From Its Most Problematic Mimickers.
   Int J Gynecol Pathol. 2026;45:437-446.
   PubMed         Abstract available
   
   
9. DA MATA S, Mora C, Silva F, Esteves S, et al
   Isolated Vaginal Recurrence of Endometrioid Endometrial Carcinoma.
   Int J Gynecol Pathol. 2026;45:454-461.
   PubMed         Abstract available
   
   
10. SEIDMAN JD, Vang R
    Untangling the Labyrinth: An Integrated View of the Mesothelial and Epithelial Linings of the Female Adnexa Based on Newly Characterized Anatomic and Histologic Junctions.
    Int J Gynecol Pathol. 2026;45:468-481.
    PubMed         Abstract available
    
    
11. RYAN M, Taylor J, McConnell L, Catherwood M, et al
    Endometrial Endometrioid Carcinomas With Signet Ring Cells: Report of a Case Series With Detailed Clinical, Pathologic, and Molecular Analysis.
    Int J Gynecol Pathol. 2026;45:447-453.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

12. LIU D, Peng Z, Zhang W, Feng C, et al
    Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial.
    Lancet Oncol. 2026 Oct 7:S1470-2045(26)00387.
    PubMed         Abstract available
    
    

    
    Mol Ther Oncol

13. LIN TC, Hsieh MR, Nguyen HDH, Visitsattapongse S, et al
    FOXM1 drives cisplatin resistance in ovarian cancer through STIM1-mediated SOCE and STAT1 activation.
    Mol Ther Oncol. 2026;34:201347.
    PubMed         Abstract available
    
    

    
    Oncogene

14. JIANG S, Jiang R, Du Y, Lu B, et al
    SMCO2 inhibits ferroptosis through the VDAC1-STAT3 axis by modulating MAM homeostasis in ovarian cancer.
    Oncogene. 2026 Oct 6. doi: 10.1038/s41388-026-03983.
    PubMed         Abstract available
    
    

    
    Oncol Rep

15. MA Y, Xu Y, Yu C, Wu H, et al
    Expression of V?domain Ig suppressor of T cell activation in ovarian cancer and its regulation of follicular regulatory T?cell function via the AKT/MAPK pathway.
    Oncol Rep. 2026;56:200.
    PubMed         Abstract available
    
    

    
    PLoS One

16. KARAGECILI S, Inan D, Ali N
    Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression.
    PLoS One. 2026;21:e0359833.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum